Compounds > bms204352
Page last updated: 2024-09-05

bms204352 and eptifibatide

bms204352 has been researched along with eptifibatide in 1 studies

Compound Research Comparison

Studies
(bms204352)		Trials
(bms204352)		Recent Studies (post-2010)
(bms204352)		Studies
(eptifibatide)		Trials
(eptifibatide)		Recent Studies (post-2010) (eptifibatide)
49112907220212

Protein Interaction Comparison

ProteinTaxonomybms204352 (IC50)eptifibatide (IC50)
Integrin beta-3Homo sapiens (human)0.226
Integrin alpha-IIbHomo sapiens (human)0.226

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1

Other Studies

1 other study(ies) available for bms204352 and eptifibatide

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008